Scientific activities of the partnership will be conducted in facilities of both St Joseph’s Hospital and Medical Center and InNexus’s GLP (Good Lab Practice) certified drug development laboratories with funding provided by research grants, the partners and strategic collaborators. Additional details were not disclosed.
Jeff Morhet, chairman and CEO of InNexus Biotechnology, said: “I am pleased to announce this new partnership between St Joseph’s Hospital and InNexus to explore, develop and commercialize new therapeutic solutions for women. We’ve already identified our first project, aimed at providing new treatments to attack the problem of endometriosis, a painful condition that can lead to other conditions, such as infertility.”
Linda Hunt, president of St Joseph’s, said: “We’re excited to join InNexus in pursuing new treatments to help women with endometriosis. We hope this is the first of many collaborations that will ultimately help patients in need.”